![Glenn Whaley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Whaley
Finansdirektör/CFO på
IMMUNIC, INC.
Förmögenhet: 142 883 $ per 2026-05-31
Profil
Mr. Glenn Whaley, CPA, is a Chief Financial Officer at Immunic, Inc., a Member at New Jersey Society of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
Mr. Whaley was previously employed as a Chief Financial Officer by Pernix Therapeutics Holdings, Inc., a Vice President-Finance by Alvogen, Inc., and a Controller by ImClone Systems, Inc. He received his undergraduate degree from Rutgers Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNIC, INC. 0,07 % | 2026-05-26 | 9 551 ( 0,07 % ) | 142 883 $ | 2026-05-31 |
Aktiva positioner av Glenn Whaley
| Företag | Position | Start |
|---|---|---|
| IMMUNIC, INC. | Finansdirektör/CFO | 2020-04-17 |
New Jersey Society of Certified Public Accountants
 New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Företagsledare/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Företagsledare/Principal | - |
Tidigare kända positioner av Glenn Whaley
| Företag | Position | Slut |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Företagsledare/Principal | 2015-03-01 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Comptroller/Controller/Revisor | 2011-05-01 |
| PERNIX THERAPEUTICS HOLDINGS INC | Finansdirektör/CFO | - |
Glenn Whaleys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
82
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
New Jersey Society of Certified Public Accountants
New Jersey Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates professional organization for certified public accountants | Commercial Services |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
